These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7981902)

  • 1. Proliferating cell nuclear antigen in breast carcinomas. An immunohistochemical study with correlation to histopathological features and prognostic factors.
    Haerslev T; Jacobsen GK
    Virchows Arch; 1994; 424(1):39-46. PubMed ID: 7981902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCNA/cyclin expression in breast carcinomas: its relationships with Ki-67, ER, PgR immunostainings and clinico-pathologic aspects.
    Tuccari G; Rizzo A; Muscarà M; Giuffrè G; Barresi G
    Pathologica; 1993; 85(1095):47-55. PubMed ID: 8100059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors affecting disease-free survival rate following surgical resection of primary breast cancer.
    Horita K; Yamaguchi A; Hirose K; Ishida M; Noriki S; Imamura Y; Fukuda M
    Eur J Histochem; 2001; 45(1):73-84. PubMed ID: 11411868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas.
    Haerslev T; Jacobsen GK; Zedeler K
    Breast Cancer Res Treat; 1996; 37(2):101-13. PubMed ID: 8750578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score.
    Tahan SR; Neuberg DS; Dieffenbach A; Yacoub L
    Cancer; 1993 Jun; 71(11):3552-9. PubMed ID: 8098267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and vimentin expression and various prognostic factors in breast cancer patients.
    Koutselini H; Markopoulos C; Lambropoulou S; Gogas H; Kandaraki C; Gogas J
    Cytopathology; 1995 Feb; 6(1):14-21. PubMed ID: 7734697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical localization of cathepsin D, proliferating cell nuclear antigen and epidermal growth factor receptor in human breast carcinoma analysed by computer image analyser: correlation with histological grade and metastatic behaviour.
    Okamura K; Kobayashi I; Matsuo K; Kiyoshima T; Yamamoto K; Miyoshi A; Sakai H
    Histopathology; 1997 Dec; 31(6):540-8. PubMed ID: 9447385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinomas: comparison with clinical and pathologic variables.
    Frierson HF
    Mod Pathol; 1993 May; 6(3):290-4. PubMed ID: 8102204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of immunohistochemically detectable metallothionein in primary breast carcinomas.
    Haerslev T; Jacobsen GK; Zedeler K
    APMIS; 1995 Apr; 103(4):279-85. PubMed ID: 7612258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunohistochemical study of p53 with correlations to histopathological parameters, c-erbB-2, proliferating cell nuclear antigen, and prognosis.
    Haerslev T; Jacobsen GK
    Hum Pathol; 1995 Mar; 26(3):295-301. PubMed ID: 7890281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative predictive value of three prognostic markers--S-phase fraction, PCNA and Mitotic count on axillary lymph node metastasis in carcinoma breast.
    Pervez S; Khan MN; Nasir MI
    J Ayub Med Coll Abbottabad; 2007; 19(1):3-5. PubMed ID: 17867469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [C-erbB-2, EGF receptor, p53 and PCNA. The prognostic significance of recent tumor markers for lymph node negative breast cancer].
    Schönborn I; Minguillon C; Lichtenegger W; Zschiesche W; Spitzer E
    Geburtshilfe Frauenheilkd; 1995 Oct; 55(10):566-71. PubMed ID: 8543129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma.
    Zekioglu O; Erhan Y; Ciris M; Bayramoglu H; Ozdemir N
    Histopathology; 2004 Jan; 44(1):18-23. PubMed ID: 14717664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1.
    Keshgegian AA; Cnaan A
    Am J Clin Pathol; 1995 Jul; 104(1):42-9. PubMed ID: 7611179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in invasive ductal carcinoma of the breast in Taiwan.
    Chu JS; Huang CS; Chang KJ
    Cancer Lett; 1998 Sep; 131(2):145-52. PubMed ID: 9851246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinoma breast.
    Aziz SA; Pervez S; Khan SM; Kayani N; Nasir MI
    J Coll Physicians Surg Pak; 2005 Apr; 15(4):225-9. PubMed ID: 15857596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
    Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of hormone receptors in invasive breast carcinoma: correlation of results of H-score with pathological parameters.
    Thike AA; Chng MJ; Fook-Chong S; Tan PH
    Pathology; 2001 Feb; 33(1):21-5. PubMed ID: 11280603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary tumour characteristics and axillary lymph node status in breast cancer.
    Yiangou C; Shousha S; Sinnett HD
    Br J Cancer; 1999 Aug; 80(12):1974-8. PubMed ID: 10471048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection of metallothionein in primary breast carcinomas and their axillary lymph node metastases.
    Haerslev T; Jacobsen K; Nedergaard L; Zedeler K
    Pathol Res Pract; 1994 Aug; 190(7):675-81. PubMed ID: 7808966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.